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1. Introduction
  The genus Neisseria comprises aerobic, Gram-negative diplococci 
and obligate human pathogens that share common properties 
such as being oxidase-positive and catalase-positive[1-3]. Neisseria 
gonorrhoeae (N. gonorrhoeae) and Neisseria meningitidis (N. 
meningitidis) are two clinically important Neisseria species 
in the family Neisseriaceae[1-3]. N. gonorrhoeae infects only 
humans and causes a spectrum of diseases including urogenital 
infections (urethritis in men and women and cervicitis in women), 
epididymitis and pelvic inflammatory disease along with 
serious reproductive health consequences in untreated infections 
(e.g. infertility in women), conjunctivitis such as ophthalmia 
neonatorum in neonates during passage via the birth canal and 
rarely disseminated gonococcal infection[4]. Gonorrhea is a 
sexually transmitted infection and the most common local infection 
caused by N. gonorrhoeae that is acquired through direct human-
to-human contact during sexual activities[4]. Despite the presence 
of effective antimicrobial treatments, gonorrhea still remains as a 
major public health issue worldwide due to dwindling of treatment 
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options. Based on the World Health Organization (WHO) reports, 
approximately 106 million people are infected with gonorrhea 
as a new infection each year[5]. Owing to the lack of any vaccine 
against N. gonorrhoeae, antibiotic therapy is the only way to 
manage gonococcal infections[6]. However, bacteria have developed 
resistance to different classes of antimicrobial agents used to treat 
the disease including penicillins, early-generation cephalosporins, 
macrolides, tetracyclines, fluoroquinolones and sulphonamides, 
resulting in increased rates of treatment failure[4,7,8]. Recently, 
WHO announced a list of bacteria divided into three categories, 
critical, high and medium, based on urgently need to develop new 
antibiotics. N. gonorrhoeae is placed in the high priority categories 
with increasingly resistance to cephalosporin and fluoroquinolone 
antibiotics[9]. Hence, it is necessary to update the healthcare systems 
with accurate information on the antibiotic resistance profile of N. 
gonorrhoeae isolates to prevent spreading of treatment failure. Similar 
to gonococcus that infect human mucosal surfaces of the genito-
urinary tract, meningococcal strains interact with mucosal surfaces 
of the nasopharynx and cause life-threatening systemic infections 
such as bacteremia, fulminant septicemia and meningitis[10]. 
Meningococcus acquired by respiratory droplets or throat secretions 
from carriers and along with Haemophilus influenza type b (Hib) 
and Streptococcus pneumonia (pneumococcus) are three important 
causative agents of bacterial meningitis characterized by stiff neck, 
sensitivity to light, high fever, headaches, confusion and vomiting as 
the most common symptoms[11]. The pathogen only infects humans 
and is responsible for 75 000 deaths within 24 to 48 hours in the 
world, but bacterial meningitis is curable and the mortality rate can 
decrease from 100% in untreated patients to less than 10% in those 
receiving effective antibiotic treatment[2,11,12]. Therefore, this fatal 
meningococcal disease is listed as a medical emergency and should 
be treated with effective antibiotics including penicillin, ampicillin, 
chloramphenicol and ceftriaxone[13]. However, evidences indicate 
increased prevalence of antibiotic-resistant meningococcal strains 
that threatens successful antibiotic therapy in a large number of 
countries[14].
  To our knowledge, there has been no previous study to present 
pooled estimates of antibiotic resistance of Neisseria species in Iran. 
The present systematic review and meta-analysis was undertaken to 
fill this gap.
2. Materials and methods
2.1. Search strategies
  This systematic review and meta-analysis was performed according 
to the Preferred Reporting Items for Systematic Reviews and Meta-
Analyses statement[15]. Until 6th July, 2018, we searched for all 
studies addressing the prevalence of antibiotic resistance of Neisseria 
species in Iran. The search was performed in major international 
databases including PubMed, Scopus and Web of Science as well as 
Iranian databases including Scientific Information Database (www.
sid.ir) and Magiran (www.magiran.com). Relevant English and 
Persian medical terms including “drug resistance” OR “antibiotic 
resistance” AND “Neisseria’’ AND “Iran” were used for searching. 
After searching reference lists to find any additional study, a 
complete list of articles were collected in a digital library for further 
evaluations and selection of eligible articles based on inclusion and 
exclusion criteria. 
2.2. Inclusion and exclusion criteria
  The titles, abstracts and full texts of numerous original studies 
were collected in a digital library and reviewed to determine their 
eligibility by two independent investigators. Our inclusion criteria 
were: (1) published cross-sectional studies in English or Persian 
languages, (2) studies which focused on antibiotic resistance 
of Neisseria species and (3) studies in an Iranian population. 
Additionally, duplicate reports and non-original articles were 
excluded.
2.3. Data extraction
  Author’s name, year of the study, location of the study, Neisseria 
species, number of isolated strains, methods used for antimicrobial 
susceptibility testing and antibiotic resistance rates of bacteria to 
different antibiotics were extracted from the included articles. 
2.4. Meta-analysis
  Antibiotic resistance rates of N. gonorrhoeae and N. meningitidis 
reported in different studies were calculated and expressed as 
percentage and 95% confidence intervals (95% CIs). Fixed- or 
random-effects models were applied to estimate pooled effect size 
on the basis of heterogeneity. Heterogeneity in study results and 
publication bias risk were determined by I2 statistic and funnel 
plots, respectively. All statistical analyses were performed by 
Comprehensive Meta-Analysis software (Biostat, Englewood, NJ).
3. Results
3.1. Characteristics of included studies
  Briefly, a total of 27 records involving 17 studies in English 
and 10 studies in Persian languages were identified following 
databases search for antibiotic resistance of Neisseria species in 
Iran. Six duplicate studies were excluded and 15 studies did not 
meet our inclusion criteria and were removed after full text review. 
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An additional 3 studies were added after checking the reference 
lists of articles and ultimately 9 studies met the inclusion criteria 
and were included in the meta-analysis. As presented in Table 1, 3 
studies from Tehran, 2 studies from Kashan, 1 study from Zahedan 
and 1 study from Mashhad evaluated the prevalence of antibiotic 
resistance of N. gonorrhoeae. Additionally, 2 studies from Tabriz and 
Hamadan reported antibiotic resistance profiles of N. meningitidis. 
In these studies, Neisseria species were collected from various 
specimens including endocervix, vagina, urethra, cerebrospinal fluid 
and blood. On the other hand, standard microbiological methods 
including samples culturing on chocolate agar, sheep blood agar 
and modified Thayer-Martin agar mediums for 48 h at 35 °曟 under 
microaerophilic condition along with biochemical tests such as 
gram staining, morphology, oxidase, catalase and carbohydrate 
utilization tests were used for bacterial identification. Figure 1 shows 
forest plots of the meta-analysis of the prevalence of N. gonorrhoeae 
resistance to ciprofloxacin, ceftriaxone, cefixime and cefepime in 
Iran. Additionally, as shown in Figure 2, there is some evidence of 
the publications bias in the study due to asymmetrical distribution of 
studies. 
3.2. Characteristics of N. gonorrhoeae antibiotic resistance
  Disk diffusion was the most frequent technique applied to 
determine antimicrobial susceptibility pattern of Neisseria species 
in Iran. The prevalence of N. gonorrhoeae resistance to different 
antibiotics was as follows: 66.9% (95% CI: 52.4-78.8) to penicillin, 
21.6% (95% CI: 3.1-70.0) to spectinomycin, 82.4% (95% CI: 46.4-
96.2) to co-trimoxazole, 52.7% (95% CI: 9.1-92.5) to tetracycline, 
29.9% (95% CI: 20.7-41.0) to gentamicin, 87.5% (95% CI: 71.1-
95.2) to ampicillin, 11.1% (95% CI: 3.2-31.7) to azithromycin, 2.2% 
(95% CI: 0.4-10.1) to chloramphenicol, and 50.0% (95% CI: 5.9-
94.1) to vancomycin (Table 2).
3.3. Are cephalosporin- and fluoroquinolone-resistant N. 
gonorrhoeae a public health problem in Iran?
  Our results in the current study showed that N. gonorrhoeae 
antibiotic resistance rate to the fluoroquinolone ciprofloxacin was 
high (59.1%; 95% CI: 43.9-72.7). On the other hand, resistance rate 
to cephalosporins including ceftriaxone (11.1%; 95% CI: 2.9-34.4) 
and cefixime (13.8%; 95% CI: 8.5-21.6) were low, with cefepime as 
the only exception (50.1%; 95% CI: 0.7-99.3). Therefore, the use of 
ciprofloxacin and cefepime for treating N. gonorrhoeae infections is 
not recommended in Iran.
Table 1
Characteristics of studies included in this meta-analysis.
First author (Ref) Year Area Bacterium
Strains
(n)
AST
Antibiotic resistance(n)
PEN CIP CRO SPT CFM TMP-SMX TET GEN AMP AZM CHL FEP VAN CTX AMK AMX KAN LEX ZOX
Zirak–Zadeh[16] 1972 Tehran N. gonorrhoeae Variable Disk diffusion 40 ND ND ND ND ND  3 ND ND 3 0 ND ND ND ND ND ND ND ND
Rahimi[17] 2007 Tehran N. gonorrhoeae 12 Disk diffusion  4 ND 0  4 ND   4 ND ND ND ND ND ND ND ND ND ND ND ND ND
Azizmohammadi[18] 2015 Tehran N. gonorrhoeae  32 Disk diffusion 22 24 2 18 5 ND 23 ND 28 6 1 ND ND ND ND ND ND ND ND
Tabasi[19] 2001 Kashan N. gonorrhoeae    2 Disk diffusion ND ND 1 ND ND ND ND ND ND ND ND ND 1 ND ND ND ND ND ND
Afrasiabi[20] 2012-2013 Kashan N. gonorrhoeae    7 Disk diffusion   7   7 7 ND ND ND ND ND ND ND ND 7 ND ND ND ND ND ND ND
Bokaeian[21] 2006-2009 Zahedan N. gonorrhoeae  77 Disk diffusion 61 41 3   2 10  72 68 23 ND ND ND 7 ND ND ND ND ND ND ND
Taghvaeii[22] 2003-2004 Mashhad N. gonorrhoeae 200 - 151 93 5 ND ND 184 ND ND ND ND ND ND ND ND ND ND ND ND ND
Abdinia[23] 2003-2013 Tabriz N. meningitidis  10 Disk diffusion     3 0 0 ND ND 0 ND 0 ND ND 0 ND ND 0 0 ND ND ND 0
Mashouf[24] 1998-2002 Hamadan N. meningitidis   9 Disk diffusion ND ND ND ND ND 0 ND 0   5 ND 0 ND ND ND ND 3 0 3 0
PEN-penicillin; CIP-ciprofloxacin; CRO-ceftriaxone; SPT-spectinomycin; CFM-cefixime; TMP-SMX-co-trimoxazole; TET-tetracycline; GEN-gentamicin; 
AMP-ampicillin; AZM-azithromycin; CHL-chloramphenicol; FEP-cefepime; VAN-vancomycin; CTX-cefotaxime; AMK-amikacin; AMX-amoxicillin; KAN-
kanamycin; LEX-cephalexin; ZOX-ceftizoxime; AST-antimicrobial susceptibility testing; ND-not determined.
Table 2
Antibiotic susceptibility profiles of N. gonorrhoeae  in different cities of Iran.
City
Antibiotic resistance (%)(95% CI)
PEN CIP CRO SPT CFM TMP-SMX TET GEN AMP AZM CHL FEP VAN
Tehran
53.7
(37.2-69.4)
75
(57.4-87)
5.7
(1.6-17.7)
47.8
(27.3-69)
15.6
(6.7-32.5)
33.3
(13.1-62.4)
29.1
(1.1-94)
ND
87.5
(71.1-95.2)
11.1
(3.2-31.7)
2.2
(0.4-10.1)
ND ND
Kashan
93.7
(46.1-99.6)
93.7
(46.1-99.6)
79.1
(21-98.2)
ND ND ND ND ND ND ND ND
93.7
(46.1-99.6)
50.0
(5.9-94.1)
Zahedan
79.2
(68.7-86.9)
53.2
(42.1-64.1)
3.9
(1.3-11.4)
2.6
(0.7-9.8)
13
(7.1-22.5)
93.5
(85.3-97.3)
88.3
(79-93.8)
29.9 
(20.7-41)
ND ND ND
9.1
(4.4-17.9)
ND
Mashhad
75.5
(69.1-81)
46.5
(39.7-53.4)
2.5(1.0-5.9) ND ND
92.0
(87.3-95)
ND ND ND ND ND ND ND
Total 
66.9
(52.4-78.8)
59.1
(43.9-72.7)
11.1
(2.9-34.4)
21.6
(3.1-70)
13.8
(8.5-21.6)
82.4
(46.4-96.2)
52.7
(9.1-92.5)
29.9 
(20.7-41)
87.5
(71.1-95.2)
11.1
(3.2-31.7)
2.2
(0.4-10.1)
50.1
(0.7-99.3)
50.0
(5.9-94.1)
PEN-penicillin; CIP-ciprofloxacin; CRO-ceftriaxone; SPT-spectinomycin; CFM-cefixime; TMP-SMX/co-trimoxazole; TET-tetracycline; GEN-gentamicin; 
AMP-ampicillin; AZM-azithromycin; CHL-chloramphenicol; FEP-cefepime; VAN-vancomycin; CTX-cefotaxime; AMK-amikacin; AMX-amoxicillin; KAN-
kanamycin; LEX-cephalexin; ZOX-ceftizoxime; ND-not determined.
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-1.00     -0.50     0.00      0.50      1.00
Meta analysis
Event rate and 95% CI
Event Lower Upper
rate Iimit Iimit Z-value P-value Total
Afrasiabi 0.938 0.461 0.996 1.854 0.064 7/7
Bokaeian 0.091 0.044 0.179 -5.809 0.000 7/77
0.501 0.007 0.993 0.002 0.998
Study name               Statistics for each study
-1.00     -0.50     0.00      0.50      1.00
Meta analysis
Event rate and 95% CI
Event Lower Upper
rate Iimit Iimit Z-value P-value Total
Afrasiabi 0.156 0.067 0.325 -3.464 0.001 5/32
Bokaeian 0.130 0.071 0.225 -5.611 0.000 10-77
0.138 0.085 0.216 -6.584 0.000
Study name                   Statistics for each study
-1.00     -0.50     0.00      0.50      1.00
Meta analysis
Event rate and 95% CI
Event Lower Upper
rate Iimit Iimit Z-value P-value Total
Afrasiabi 0.038 0.002 0.403 -2.232 0.026 0/12
Azizmohammacdi 0.063 0.016 0.218 -3.708 0.000 2-32
Tabasi 0.500 0.059 0.941 0.000 1.000 1-2
Afrasiabi 0.938 0.461 0.996 1.854 0.064 7/7
Bokaeian 0.025 0.010 0.059 -8.089 0.000 5/200
Taghvaeii 0.111 0.029 0.344 -2.847 0.004
Study name                 Statistics for each study
Event Lower Upper
rate Iimit Iimit Z-value P-value Total
Azizmohammacdi 0.750 0.574 0.870 2.691 0.007 21/32
Afrasiabi 0.938 0.461 0.996 1.854 0.064 7/7
Bokaeian 0.532 0.421 0.641 0.569 0.5569 41/77
Taghvaeii 0.465 0.397 0.534 -0.989 0.323 93/200
0.591 0.439 0.727 1.177 0.239
Event rate and 95% CIStudy name                 Statistics for each study
Meta analysis
-1.00     -0.50     0.00      0.50      1.00
C
D
B
A
Figure 1. Forest plots of the meta-analysis of the prevalence of N. 
gonorrhoeae resistance to ciprofloxacin, ceftriaxone, cefixime and cefepime 
in Iran.  
A: Ciprofloxacin; B: Ceftriaxone; C: Cefixime; D: Cefepime.
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Figure 2. Funnel plots of the meta-analysis of the prevalence of N. 
gonorrhoeae resistance to ciprofloxacin and ceftriaxone in Iran.  
Funnel plot analysis was not performed for cefixime and cefepime resistance 
rates owing to the insufficient number of studies (n=2).
3.4. Characteristics of N. meningitidis antibiotic resistance
  As shown in Table 3, the prevalence of N. meningitidis resistance 
to different antibiotics was as follows: 30.0%  (95% CI: 10.0-62.4) 
to penicillin, 33.3%  (95% CI: 11.1-66.7) to amoxicillin, 33.3% 
(95% CI: 11.1-66.7)  to cephalexin, 55.6% (95% CI: 25.1-82.3) 
to ampicillin and 0.0% to ciprofloxacin, ceftriaxone, cefotaxime, 
amikacin, co-trimoxazole, gentamicin, kanamycin, chloramphenicol 
and ceftizoxime.
4. Discussion
  The emergence of antibiotic-resistant N. gonorrhoeae strains 
has led to some problems in the prevention and control of 
gonococcal infections[6,25]. The spread of resistance to the last-
line cephalosporins, penicillins, sulfonamides, tetracyclines, 
quinolones and macrolides has limited treatment options for N. 
Table 3
Antibiotic susceptibility profiles of N. meningitidis in different cities of Iran.
City
Antibiotic resistance (%)(95% CI)
PEN CIP CRO CTX AMK TMP-SMX AMX GEN AMP KAN CHL LEX ZOX
Tabriz 30(10.0-62.4) 0 0 0 0 0 ND 0 ND ND 0 ND 0
Hamadan ND ND ND ND ND 0 33.3(11.1-66.7) 0 55.6(25.1-82.3) 0 0 33.3(11.1-66.7) 0
Total 30(10.0-62.4) 0 0 0 0 0 33.3(11.1-66.7) 0 55.6(25.1-82.3) 0 0 33.3(11.1-66.7) 0
  PEN-penicillin; CIP-ciprofloxacin; CRO-ceftriaxone; SPT-spectinomycin; CFM-cefixime; TMP-SMX/co-trimoxazole; TET-tetracycline; GEN-gentamicin; 
AMP-ampicillin; AZM-azithromycin; CHL-chloramphenicol; FEP-cefepime; VAN-vancomycin; CTX-cefotaxime; AMK-amikacin; AMX-amoxicillin; KAN-
kanamycin; LEX-cephalexin; ZOX-ceftizoxime; ND-not determined.
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gonorrhoeae infections and can lead to increased morbidity and 
mortality rates, a conditions resemble the pre-antibiotic era[6,25]. 
Therefore, it is important to obtain accurate information on the 
nationwide and global antibiotic susceptibility profile of Neisseria 
species to guide the treatment of infected patients. In the present 
study, antibiotic resistance of N. gonorrhoeae and N. meningitidis to 
毬-lactam antibiotics and other antibiotics inhibiting bacterial cell 
wall synthesis including penicillins, cephalosporins and vancomycin 
were summerized. According to our results, antibiotic resistance 
of N. gonorrhoeae to penicillins, such as penicillin (66.9%) and 
ampicillin (87.5%), and vancomycin (50.0%) was high. A review 
of other studies shows that drug resistance findings varies widely 
among countries such as Germany (penicillin, 18.8%), Tunisia 
(penicillin, 55.3%) and Korea (penicillin, 100%)[9,26,27]. Similar 
resistance rates were observed for N. meningitidis strains: penicillin 
(30.0%), ampicillin (55.6%) and amoxicillin (33.3%). The results of 
other studies are as follows: 30.4% in Tunisia, 0.0% in Scotland, and 
40.9% in Belgium[26]. Major mechanisms of antimicrobial resistance 
of N. gonorrhoeae and N. meningitidis to 毬-lactam antibiotics 
including (1) TEM-1 type 毬-lactamase-encoding plasmids and 
(2) chromosomally mediated resistance by the modification of 
ponA and penA genes that encode penicillin-binding protein 1 and 
2 (PBP1 and 2), mtrR gene that encodes efflux pump, porB gene 
that encodes outer membrane porin and pilQ gene that encodes 
a component of the gonococcal outer membrane. Enzymatic 
destruction of the antibiotic and the last two resistance genes are 
most often contributed to N. gonorrhoeae[4,10,26]. Included studies 
did not investigate the mechanisms of resistance to antibiotics in 
the Iranian isolates. For gonorrhea treatment, third-generation of 
cephalosporins and quinolones were proposed[1]. However, WHO 
reported that resistance to third-generation cephalosporins has 
emerged in some geographic areas such as the United Kingdom, 
Norway, Sweden, Australia, Japan and China[28]. In Iran, gonococcal 
resistance rate to cephalosporins including ceftriaxone (11.1%), 
cefixime (13.8%) and cefepime (50.1%) were variable. Therefore, 
as WHO reported, cefepime-resistant N. gonorrhoeae can be a threat 
to human health in Iran[9]. Additionally, meningococcal antibiotic 
resistance to cephalosporins such as ceftriaxone (0.0%), cefotaxime 
(0.0%) and ceftizoxime (0.0%) were low, with cephalexin (33.3%) 
as the only exception. The antibiotic of choice for meningococcal 
infections therapy is penicillin G[2]. However, treatment can be 
changed to ceftriaxone or cefotaxime if the organism is penicillin-
resistant[2]. In Iran, according to the present results, meningococcal 
resistance to penicillin is high. Therefore, the use of ceftriaxone or 
cefotaxime instead of penicillin is recommended. Ciprofloxacin, 
a quinolone antibiotic which acts via inhibition of bacterial DNA 
synthesis by interfering with the DNA gyrase and topoisomerase 
IV enzymes, along with ceftriaxone are commonly prescribed as 
chemoprophylaxis drugs against meningococcal infection[26]. In 
the current study, resistance of N. meningitidis to ciprofloxacin was 
0.0% but high rates of resistance were detected in N. gonorrhoeae 
strains (59.1%). This result in the current meta-analysis is consistent 
with WHO’s concerns about the emergence of fluoroquinolone-
resistant N. gonorrhoeae in the world [9]. Ciprofloxacin resistance of 
Neisseria species can be achieved through mutations in genes gyrA, 
gyrB, parC, parE and mtrR, and there have been reports of emerging 
ciprofloxacin-resistant N. meningitidis strains in Australia, France, 
Spain, Argentina and Hong Kong[26]. Gonococcal and meningococcal 
resistance to antibiotics inhibiting protein synthesis were evaluated 
in the current meta-analysis and the results showed a low resistance 
rate to gentamicin, amikacin, kanamycin and chloramphenicol in N. 
meningitidis. However, N. gonorrhoeae resistance to spectinomycin, 
tetracycline and gentamicin was high. Chloramphenicol resistance 
is mediated by chloramphenicol acetyltransferase enzyme (encoded 
by cat genes) but the global resistance of Neisseria species to this 
antibiotic is low[26]. Similar results were found in the present study 
and N. meningitidis (0.0%) and N. gonorrhoeae (2.2%) showed low 
resistance rates to chloramphenicol. Spectinomycin and tetracycline, 
especially in patients allergic to penicillin, have been suggested 
as alternatives to treat gonorrhea and act via blocking bacterial 
protein synthesis by binding to the 30S ribosomal subunit[4,6,26]. 
Unlike some countries like South Korea in which susceptibility 
to spectinomycin is high (100.0%), in Iran 21.6% of strains were 
resistant to this antibiotic[27]. Based on WHO reports, there are high 
rates of tetracycline resistance worldwide and in the majority of 
countries gonorrhea treatment with this drug is not recommended[28]. 
Similar to other countries, tetracycline resistance in N. gonorrhoeae 
was high in Iran (52.7%). In N. gonorrhoeae, mechanisms of 
resistance may be attributed to the mutations of mtrR, penB, pilQ and 
tetM genes[4]. However, none of the included studies investigated 
the mechanisms underlying resistance. Due to the resistance of 
N. gonorrhoeae to first-line antibiotics as well as the extended-
spectrum cephalosporins that lead to treatment failure, the Centers 
for Disease Control and Prevention recommended combination 
therapy with ceftriaxone and azithromycin or doxycycline, and this 
therapeutic regimen has been used in many regions such as USA, 
Asia and Europe[2,27]. In light of the present study, the antimicrobial 
susceptibility of N. gonorrhoeae to azithromycin was low (11.1%) 
in Iran. Similar results were reported from Germany (11.9%) and 
Korea (5%)[9,27]. Azithromycin binds to the 50S ribosomal subunit 
and inhibits bacterial protein synthesis. Mutations in the 23S rRNA 
and mtrR genes play a major role in the resistance to this macrolide 
antibiotic[4,29]. In the late 1930s, sulphonamides, which prevent 
folic acid synthesis in bacteria, were used to treat gonorrhea[1,4]. 
However, N. gonorrhoeae isolates resistant to these drugs were soon 
identified and the use of these drugs was stopped in many countries 
such as USA[4]. In this meta-analysis, we observed a high level of 
co-trimoxazole resistance in N. gonorrhoeae strains (82.4%) in Iran. 
However, while sulfonamides have lost their effectiveness against 
meningococcal infections due to the spread of resistant strains, co-
trimoxazole resistance rate was 0% in N. meningitidis isolates of 
Iran[1].
  To conclude, high rates of gonococcal resistance to penicillin, 
ciprofloxacin, co-trimoxazole, tetracycline, gentamicin, ampicillin, 
cefepime and vancomycin were detected in the current study. 
Therefore, the use of these antibiotics is not recommended for the 
treatment of gonococcal infection in Iran. Furthermore, penicillin, 
amoxicillin, ampicillin and cephalexin are not suitable antibiotics to 
13Farzad Khademi et al./Asian Pacific Journal of Tropical Medicine 2019; 12(1): 8-13
treat meningococcal infections in Iran. Overall, global and national 
monitoring of antibiotic resistance profile of Neisseria isolates is 
fundamental to guide proper treatment and prevent spreading of 
resistant species. Finally, further research is required to evaluate the 
major mechanisms involved in the acquisition of antibiotic resistance 
in Neisseria species.
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